| $385M | ||
| $350M | ||
| $215M | ||
| $88M | ||
| $82M | ||
| $62M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Over the last 12 months, insiders at Acurx Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Acurx Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Acurx Pharmaceuticals, Inc. have bought $159,806 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 49,261 shares for transaction amount of $50,000 was made by LUCI DAVID P (President and CEO) on 2025‑01‑06.
| 2025-01-06 | LUCI DAVID P | President and CEO | 49,261 0.2642% | $1.01 | $50,000 | -67.22% | ||
| 2025-01-06 | DELUCCIA ROBERT J | 49,261 0.2642% | $1.01 | $50,000 | -67.22% | |||
| 2025-01-06 | Sailer Carl | director | 24,631 0.1321% | $1.01 | $25,000 | -67.22% | ||
| 2025-01-06 | Scodari Joseph C | director | 24,631 0.1321% | $1.01 | $25,000 | -67.22% | ||
| 2025-01-06 | Donohue James J. | director | 9,852 0.0528% | $1.01 | $10,000 | -67.22% | ||
| 2025-01-06 | DEAN JACK H | director | 9,852 0.0528% | $1.01 | $10,000 | -67.22% | ||
| 2021-11-23 | Sailer Carl | director | 5,161 0.0628% | $4.84 | $24,979 | -21.67% | ||
| 2021-11-19 | DELUCCIA ROBERT J | 5,034 0.0595% | $4.90 | $24,672 | -24.69% | |||
| 2021-11-19 | LUCI DAVID P | President and CEO | 5,200 0.0602% | $4.80 | $24,960 | -24.69% | ||
| 2021-06-29 | Sailer Carl | director | 12,500 0.1719% | $6.00 | $75,000 | -30.67% |
| LUCI DAVID P | President and CEO | 1097458 69.2412% | $2.16M | 2 | 0 | <0.0001% |
| DELUCCIA ROBERT J | 1010196 63.7356% | $1.99M | 2 | 0 | <0.0001% | |
| Sailer Carl | director | 137183 8.6552% | $270,250.51 | 3 | 0 | <0.0001% |
| Scodari Joseph C | director | 27708 1.7482% | $54,584.76 | 1 | 0 | <0.0001% |
| Donohue James J. | director | 22352 1.4102% | $44,033.44 | 1 | 0 | <0.0001% |
| DEAN JACK H | director | 21776 1.3739% | $42,898.72 | 1 | 0 | <0.0001% |
$1,848,072 | 66 | -14.67% | $2.53M | |
$13,664,154 | 40 | -70.35% | $5.12M | |
$1,138,733 | 28 | -4.94% | $3.28M | |
$29,635,355 | 27 | 9.05% | $4.26M | |
$337,688 | 19 | -33.30% | $4.25M | |
$105,917 | 11 | -28.06% | $2.42M | |
$684,058 | 11 | -57.59% | $4.94M | |
$18,269 | 10 | -21.15% | $2.32M | |
$126,023 | 10 | -66.17% | $2.83M | |
$90,087 | 9 | 20.06% | $2.32M | |
$8,971,546 | 8 | 6.18% | $4.17M | |
Acurx Pharmaceuticals, Inc. (ACXP) | $245,000 | 7 | -62.00% | $3.12M |
$192,099 | 7 | -39.17% | $5.03M | |
$7,268,979 | 7 | -48.44% | $2.54M | |
$76,299 | 4 | 11.60% | $4.93M | |
$149,778 | 4 | -45.16% | $3.08M | |
$4,423 | 2 | 3.27% | $4.8M | |
$37,000 | 1 | 79.42% | $2.74M | |
$9,963 | 1 | -14.25% | $2.47M |
| Increased Positions | 11 | +34.38% | 50,187 | +44.23% |
| Decreased Positions | 14 | -43.75% | 77,989 | -68.74% |
| New Positions | 5 | New | 23,976 | New |
| Sold Out Positions | 11 | Sold Out | 77,283 | Sold Out |
| Total Postitions | 29 | -9.38% | 85,657 | -24.5% |
| Prospect Financial Services Llc | $55.00 | 0.99% | 19,883 | +5,044 | +33.99% | 2025-09-30 |
| Susquehanna International Group, Llp | $46.00 | 0.84% | 16,815 | +13,328 | +382.22% | 2025-09-30 |
| Sabby Management, Llc | $24.00 | 0.44% | 8,705 | +4,610 | +112.58% | 2025-09-30 |
| Osaic Holdings, Inc. | $22.00 | 0.39% | 7,824 | +7,301 | +1,395.98% | 2025-09-30 |
| Morgan Stanley | $15.00 | 0.27% | 5,310 | 0 | 0% | 2025-09-30 |
| Nbc Securities, Inc. | $4.00 | 0.08% | 1,500 | 0 | 0% | 2025-09-30 |
| Gps Wealth Strategies Group, Llc | $3.00 | 0.06% | 1,225 | +50 | +4.25% | 2025-09-30 |
| Tower Research Capital Llc (Trc) | $3.00 | 0.05% | 1,077 | +869 | +417.79% | 2025-09-30 |
| Citigroup Inc | $1.00 | 0.02% | 453 | +453 | New | 2025-09-30 |
| Group One Trading Llc | $1.00 | 0.02% | 298 | -382 | -56.18% | 2025-09-30 |